Outlook Therapeutics Inc (OTLK)

Apr 13, 2026

Breakouts Watch: Will Outlook Therapeutics Inc benefit from AI trends2026 Big Picture & Low Drawdown Trading Strategies - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Plus Therapeutics Inc (PSTV) Stock Price, Quote, News & History - Benzinga

Apr 10, 2026

Apr 08, 2026

H.C. Wainwright Maintains Outlook Therapeutics(OTLK.US) With Hold Rating, Maintains Target Price $0.5 - Moomoo

Apr 08, 2026

Apr 08, 2026

Outlook Therapeutics files dispute resolution request with FDA By Investing.com - Investing.com India

Apr 08, 2026

Apr 08, 2026

Outlook Therapeutics’ Formal Dispute Resolution for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA for Wet AMD Approval Pathway 1 - Minichart

Apr 08, 2026

Apr 08, 2026

Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA - Sahm

Apr 08, 2026

Apr 08, 2026

Outlook Therapeutics Files FDA Resolution Request After Rejection For Vision Loss Drug - Sahm

Apr 08, 2026

Apr 07, 2026

Outlook Therapeutics Pursues FDA Dispute Resolution for ONS-5010 - TipRanks

Apr 07, 2026

Apr 07, 2026

FDA accepts Outlook Therapeutics (NASDAQ: OTLK) dispute request on LYTENAVA - Stock Titan

Apr 07, 2026

Apr 07, 2026

Outlook Therapeutics request for FDA dispute resolution on ONS-5010 accepted - Traders Union

Apr 07, 2026

Apr 07, 2026

Outlook Therapeutics (OTLK) Seeks FDA Review for ONS-5010 Approval - GuruFocus

Apr 07, 2026

Apr 07, 2026

Outlook Therapeutics files dispute resolution request with FDA - Investing.com

Apr 07, 2026

Apr 07, 2026

Outlook Therapeutics Announces Formal Dispute Resolution Request For Ons-5010/Lytenava™ (Bevacizumab-Vikg) Accepted By FDA - TradingView — Track All Markets

Apr 07, 2026

Apr 07, 2026

FDA accepts Outlook dispute request, sets April eye-drug meeting - Stock Titan

Apr 07, 2026

Apr 06, 2026

Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA (bevacizumab-vikg) Accepted by FDA - Bitget

Apr 06, 2026

Apr 06, 2026

Outlook Therapeutics (OTLK) price target decreased by 27.91% to 3.95 - msn.com

Apr 06, 2026

Apr 05, 2026

Outlook Therapeutics, Inc. (OTLK) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union

Apr 05, 2026

Apr 04, 2026

Outlook Therapeutics (XTER:41O) PE Ratio : N/A (As of Apr. 04, 2026) - GuruFocus

Apr 04, 2026

Apr 04, 2026

Outlook Therapeutics (XTER:41O) PB Ratio : (As of Apr. 04, 2026) - GuruFocus

Apr 04, 2026

Apr 03, 2026

Live Outlook Therapeutics, Inc. (OTLK) Technical Analysis - Traders Union

Apr 03, 2026

Apr 02, 2026

Is Outlook Therapeutics Inc a top pick in the sectorEarnings Risk Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn

Apr 02, 2026

Apr 02, 2026

Outlook Therapeutics Inc (41O.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 02, 2026

Apr 01, 2026

OTLK SEC FilingsOutlook Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 01, 2026

Apr 01, 2026

OTLK Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 01, 2026

Mar 31, 2026

Institution Moves: Will Outlook Therapeutics Inc outperform the market in YEAR2026 Gainers & Long-Term Capital Growth Strategies - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Outlook Therapeutics (OTLK) Price Target Increased by 11.90% to 9.59 - msn.com

Mar 31, 2026

Mar 30, 2026

Can Outlook Therapeutics Inc reach all time highs this year2026 Bull vs Bear & Comprehensive Market Scan Insights - baoquankhu1.vn

Mar 30, 2026

Mar 26, 2026

Why Is OTLK Stock Falling Today? - Stocktwits

Mar 26, 2026

Mar 26, 2026

Profit Recap: Is Outlook Therapeutics Inc stock a buy or sell2026 Technicals & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Mar 26, 2026

Mar 26, 2026

Outlook Therapeutics Completes Dilutive Equity Offering With Warrants - The Globe and Mail

Mar 26, 2026

Mar 26, 2026

Outlook Therapeutics closes $5 million stock offering By Investing.com - Investing.com Australia

Mar 26, 2026

Mar 26, 2026

Published on: 2026-03-26 16:05:05 - baoquankhu1.vn

Mar 26, 2026

Mar 26, 2026

Outlook Therapeutics Announces $500,000 Public Offering of Common Stock and Warrants - Minichart

Mar 26, 2026

Mar 25, 2026

Outlook Therapeutics closes 5.0 million dollar public offering to boost capital - Traders Union

Mar 25, 2026

Mar 25, 2026

Outlook Therapeutics commences $5.0M best-efforts offering of common stock with 1-for-1 warrants - TradingView — Track All Markets

Mar 25, 2026

Mar 25, 2026

[8-K] Outlook Therapeutics, Inc. Reports Material Event - Stock Titan

Mar 25, 2026

Mar 25, 2026

Outlook Therapeutics closes $5 million stock offering - Investing.com

Mar 25, 2026

Mar 25, 2026

Outlook Therapeutics Announces Closing of $5.0 Million Public Offering - The Manila Times

Mar 25, 2026

Mar 25, 2026

Outlook Therapeutics (OTLK) launches 20M-share offering with detachable warrants - Stock Titan

Mar 25, 2026

Mar 25, 2026

Outlook Therapeutics prices $5M stock offering at $0.25 per share - au.investing.com

Mar 25, 2026

Mar 25, 2026

Outlook Therapeutics Announces Proposed Public Offering - Sahm

Mar 25, 2026

Mar 24, 2026

Outlook Therapeutics stock prices $5M offering at $0.25 per share amid Nasdaq plunge and biotech fun - AD HOC NEWS

Mar 24, 2026

Mar 24, 2026

Outlook Therapeutics Shares Drop After $5 Million Public Offering Priced - marketscreener.com

Mar 24, 2026

Mar 24, 2026

Why is OTLK stock falling today? - MSN

Mar 24, 2026

Mar 24, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Mar 24, 2026

Mar 24, 2026

Outlook Therapeutics Announces Pricing of $5.0 Million Public Offering - ChartMill

Mar 24, 2026

Mar 24, 2026

Biggest stock movers Tuesday: CLB, OTLK, and more (NASDAQ:NTGR) - Seeking Alpha

Mar 24, 2026

Mar 24, 2026

Outlook Therapeutics launches public stock offering By Investing.com - ca.investing.com

Mar 24, 2026